Skip to content

Deep Breathing With and Without Pressure Support and PEEP for Preoxygenation in Obese Patients

Effects of Pressure Support and Positive End-Expiratory Pressure Added to Deep Breathing Preoxygenation on Gastric Distension in Obese Patients: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07380425
Enrollment
75
Registered
2026-02-02
Start date
2021-12-01
Completion date
2022-07-25
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Preoxygenation, obesity, Pressure Support Ventilation, Positive End-Expiratory Pressure, Gastric Antrum Area

Brief summary

Obese patients are at increased risk of low oxygen levels during the induction of general anesthesia. Preoxygenation with a face mask before anesthesia is routinely used to increase oxygen reserves. This study compares three preoxygenation techniques: deep breathing alone, deep breathing with pressure-supported ventilation, and deep breathing with pressure-supported ventilation plus positive end-expiratory pressure (PEEP). The main goal of the study is to determine how quickly each technique allows patients to reach an adequate level of oxygen in the lungs. In addition, the study evaluates whether these techniques cause gastric distension, which could increase the risk of regurgitation. Gastric ultrasound is used to assess stomach size before and after preoxygenation. The results of this study will help identify the most effective and safest method of preoxygenation in obese patients undergoing elective surgery.

Interventions

PROCEDUREDeep Breathing Preoxygenation

Preoxygenation performed with deep breathing using a ventilator delivering 100% oxygen at a flow rate of 12 L/min.

PROCEDUREPressure Support Ventilation

Application of pressure support ventilation with a pressure support level of 12 cmH₂O during preoxygenation.

PROCEDUREPositive End-Expiratory Pressure

Application of positive end-expiratory pressure at a level of 6 cmH₂O during preoxygenation.

Sponsors

Pamukkale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Three-arm parallel-group randomized trial comparing deep breathing alone, deep breathing with pressure support, and deep breathing with pressure support plus PEEP for preoxygenation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Obesity * Scheduled for elective surgery under general anesthesia * Able to cooperate with deep breathing during preoxygenation

Exclusion criteria

* Hemodynamic instability * Poor cooperation * Preoperative oxygen therapy requirement * Conditions in which positive pressure ventilation may be harmful (e.g., increased intracranial or intraocular pressure) * Pregnancy * Emergency surgery * Beard (preventing adequate face mask seal) * Previous gastric surgery * Inability to visualize the gastric antrum by ultrasonography

Design outcomes

Primary

MeasureTime frameDescription
Time to reach an end-tidal oxygen concentration (EtO₂) of 90%Periprocedural (during the preoxygenation period, prior to induction of anesthesia)The time, in seconds, from the start of preoxygenation until the end-tidal oxygen concentration (EtO₂) reached 90%. End-tidal oxygen was measured at 30-second intervals using the anesthesia machine gas analyzer. Reaching EtO₂ 90% was defined as the endpoint of the preoxygenation period.

Secondary

MeasureTime frameDescription
Heart ratePeriprocedural (baseline and pre-induction)Heart rate was measured at baseline (before the start of preoxygenation) and at the end of the preoxygenation period, defined as the time point when end-tidal oxygen concentration (EtO₂) reached 90%.
Gastric antral cross-sectional areaPeriprocedural (baseline and pre-induction)Gastric antral cross-sectional area measured by ultrasonography using a 2-5 MHz convex probe, calculated as (anteroposterior diameter × craniocaudal diameter × π)/4. Measurements were performed at baseline (before the start of preoxygenation) and at the completion of the preoxygenation period, defined as the time point when end-tidal oxygen concentration (EtO₂) reached 90%.
Gastric distension scorePeriprocedural (baseline and pre-induction)Epigastric gastric distension assessed using a 4-point ordinal scale (0 = none, 1 = mild, 2 = moderate, 3 = marked). The score was recorded at baseline (before the start of preoxygenation) and at the completion of the preoxygenation period, defined as the time point when end-tidal oxygen concentration (EtO₂) reached 90%.
Reflux, belching, and discomfortPeriprocedural (baseline and pre-induction)Patient-reported occurrence of discomfort, symptomatic gastroesophageal reflux, or belching during the preoxygenation period. Events were assessed and recorded at the completion of the preoxygenation period, defined as the time point when end-tidal oxygen concentration (EtO₂) reached 90%.
Systolic Blood PressurePeriprocedural (baseline and pre-induction)Systolic blood pressure measured noninvasively at baseline (before the start of preoxygenation) and at the completion of the preoxygenation period, defined as the time point when end-tidal oxygen concentration (EtO₂) reached 90%.
Diastolic Blood PressurePre-induction (baseline and at completion of preoxygenation, defined by EtO₂ reaching 90%)Diastolic blood pressure measured noninvasively at baseline (before the start of preoxygenation) and at the completion of the preoxygenation period, defined as the time point when end-tidal oxygen concentration (EtO₂) reached 90%.
Peripheral Oxygen Saturation (SpO₂)Periprocedural (baseline and pre-induction)Peripheral oxygen saturation (SpO₂) measured at baseline (before the start of preoxygenation) and at the completion of the preoxygenation period, defined as the time point when end-tidal oxygen concentration (EtO₂) reached 90%.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026